chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report was received from a health care professional on 11/10/03 concerning a 3 year old male vaccinee who inadvertently received Fluvirin on 11/4/03. On 11/4/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting, the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Information has been received from a certified medical assistant concerning a male patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX (Lot # 661577/1161X) and had injection site reactions from PNEUMOVAX.  It is unknown if the patient sought medical attention. At the time of reporting, it is unknown if the patient had recovered.  This is one of several cases received from the same source.  Additional information has been requested.
Information has been received from a physician concerning a "6 month old" female who in "July 2009", was vaccinated (oral administration) with the third dose of ROTATEQ (dose, lot# not reported). It was reported that the patient was diagnosed with rotavirus after receiving her third dose of ROTATEQ in "July 2009". The patient was hospitalized for dehydration but the length of stay and specific hospital were unknown. Additional information has been requested.
Patient came in around 4:45pm to receive a seasonal flu vaccine and Spikevax covid 19 vaccine 2023-2024 While elvaulating the consent form, patient informed me that he has a vasovagel event last year when receiving his vaccinations. He was cleared by the emergency room department ,stating that it was not believed to be an allergic reaction. Patient was accompanied by his parents. The patient wanted to proceed with vaccination, within in 1 to 2 minutes patient stated he did not fill well, rolled his eyes and fainted. He woke up immediately but then had a brief seizure. EMS was called immediately. Patient was able to tell us his DOB and was responding. The paramedics evaulated him. Helwent to the hospital .
4 days later I woke with my neck and left upper back hurting. Then realized that the pain was with each breath. My muscles hurt and I had a migraine. Breathing got hard by 3pm, and worse when I started making phone calls because I thought maybe it was covid. It took two and a half hours to find a place that would do a covid test which came back showing I did not have covid. Breathing continue to get worse. I used in Albuterol, starting using zinc lozenges because they said they didn't know if the test was accurate because of how soon I came in from when the symptoms started. At 9 p.m. I started Azithromycin-250-mg-oral. I continue struggling to breathe until today September 1st.
On 5/8/21, patient went to Urgent Care clinic for fever, discharged home. On 5/9/21, patient was admitted to ER for 24hrs  for "staring spells" and fever. Suspected seizure activity.   Parents of patient state child has rash and irritation at injection site and wanted reaction reported and allergy to "hib" to be placed in chart.
weakness; could not receive the second dose for 90 days after the infusion; sleep alot; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (could not receive the second dose for 90 days after the infusion), HYPERSOMNIA (sleep alot) and FATIGUE (fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (could not receive the second dose for 90 days after the infusion), HYPERSOMNIA (sleep alot) and FATIGUE (fatigue). At the time of the report, ASTHENIA (weakness), HYPERSOMNIA (sleep alot) and FATIGUE (fatigue) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (could not receive the second dose for 90 days after the infusion) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, SARS-CoV-2 test: positive (Positive) tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  The patient received antibody infusion (not specified) on 12-Apr-2021 for treatment of COVID-19.  For mRNA-1273 (COVID 19 Vaccine Moderna), the reporter did not provide any causality assessments.    This case was linked to MOD21-108548 (E2B Linked Report).; Sender's Comments:  MOD21-108548:MOD21-108548 (husband case)
When pt was administered the 1st dose several hours later pt was seen in the ED for bells palsy symptoms, made aware about symptoms returning for the second dose, cleared by personal physician and neurologist.
Very sore arm at site, manifested thru out entire arm and chest to include shoulder within 2 hours of shot.  Within a week contracted COVID Arm and floaters in left eye.  Currently arm is better, but still have redness and floaters in left eye.  Am due for my second vaccine this week, and fearful of side effects
Autoimmune disease Temporal Arteritis diagnosed July 7, 2018 at Hospital after loss of vision in left eye and over a month of severe excruciating headaches.
Painful swelling all around the left hip. Redness, rash and hives at the injection site. Hot to the touch
Patient reported noticing muscle aching and being very tired.  She didn't have any side effects or notice anything right after the vaccine.  This is now over 2 weeks later.  It began yesterday...and was getting better today.
12/23/2021 I started have really bad pain in my arms and in between my shoulder blades. I stayed in bed all day. I went to the hospital on January 10, 2022, they ran all the test for the heart and blood work. All test came back normal and I got to go home. I saw the doctor on January 13, 2022, and they thought it might be arthritis. The pain comes and goes.
Red, Hot, Sore and Raised Skin discoloration.  Entire lateral leg.
Client complained of severe migraine headache vomiting and sore throat x 2 days. Client did not go to the hospital. Client is doing fine at the moment she said. No treatment given.
her vaccinated right arm hurt; slight headache; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (her vaccinated right arm hurt) and HEADACHE (slight headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028K21A, 040A21A and 031R21A) for COVID-19 prophylaxis.     The patient's past medical history included Cancer in 2019, Chemotherapy in 2019 and Radiation therapy in 2019. Concurrent medical conditions included Epilepsy (since teenage years). Concomitant products included PRIMIDONE (MYSOLINE) for Epilepsy, COLECALCIFEROL (VIT D3) for an unknown indication.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (her vaccinated right arm hurt) and HEADACHE (slight headache). At the time of the report, VACCINATION SITE PAIN (her vaccinated right arm hurt) and HEADACHE (slight headache) outcome was unknown.            Patient has had Epilepsy, and she stated the Epilepsy medication makes her whole body slow. That's why she was slow to respond. Patient's whole system was like that, just in general without a vaccination, that's just from every day. She stated that part didn't change after vaccination. She took Vit D3, and the doctor had asked her to monitor her High Blood Pressure. Patient did mention that they were monitoring her blood pressure and have not prescribed any medication for it.   No treatment information was reported.   This case was linked to MOD-2023-748135, MOD-2023-748129 (Patient Link).
Pt developed bilateral tinnitus after her second covid vaccine that lasted for 2 weeks. No treatment was provided for symptoms as pt just reported to health care facility now.
After administration of HAVRIX, pt felt faint, light headedness and hard of hearing and fingers cramping within 5 mins of receiving vaccine. Prior to administration, pt felt nervous but reported no adverse rxns to any other vaccines. Pt does report that similar feelings have occurred due to menstruation. Pt did not report hives or shortness of breath. Possible anxiety attack or due to vaccine unknown. Pt later recovered and was able to leave pharmacy when symptoms resolved.
1:30 appt. vaccine administered by staff MA. I felt pain and swelling around 4. Left work early. By 5:30 it was rock hard and losing ability to lift my left arm. All night and next day felt frozen and couldn't move (L) arm much w/out (Rt) arm lifting it.
arm pain; fatigue more than normal; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm pain) and FATIGUE (fatigue more than normal) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm pain) and FATIGUE (fatigue more than normal). At the time of the report, VACCINATION SITE PAIN (arm pain) and FATIGUE (fatigue more than normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information use was not reported.  Treatment information was not provided.
Left thigh had vaccines of MMR, Varicella and flu given. Now with erythema 3" diameter and fluid filled vesicles 1" diameter within erythema. Edema of thigh as well, fussy child.
Peripheral neuropathy; numbness in left hand; tingling in right arm and feet and ankles; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 29Mar2021 08:30 (Lot number: ER8737) at the age of 37 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: MICROGESTIN (ongoing). Vaccination history included: Bnt162b2 (Dose 1, Date: 08Mar2021, Time: 08:30 , Anatomical Site of injection: left Arm, Route of Administration: Intramuscular, Batch/Lot number: EN6199, Illness/AE: Vertigo, Onset date: 09Mar2021, Stop date: 23Mar2021), administration date: 08Mar2021, when the patient was 37 years old, for Covid-19 Immunization, reaction(s): "vertigo"; Bnt162b2 (Dose 1, Date: 08Mar2021, Time: 08:30 , Anatomical Site of injection: left Arm, Route of Administration: Intramuscular, Batch/Lot number: EN6199, Illness/AE: Dizzyness, Onset date: 24Mar2021, Stop date: Ongoing, Pertinent Details: Vertigo improved to general dizziness), administration date: 08Mar2021, when the patient was 37 years old, for Covid-19 immunization, reaction(s): "Dizziness". The following information was reported: NEUROPATHY PERIPHERAL (medically significant) with onset 29Mar2021 08:35, outcome "not recovered", described as "Peripheral neuropathy"; HYPOAESTHESIA (non-serious) with onset 29Mar2021 08:35, outcome "not recovered", described as "numbness in left hand"; PARAESTHESIA (non-serious) with onset 29Mar2021 08:35, outcome "not recovered", described as "tingling in right arm and feet and ankles". The events "peripheral neuropathy", "numbness in left hand" and "tingling in right arm and feet and ankles" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: blood cholinesterase: (10May2021) negative; blood thyroid stimulating hormone: (02Jun2021) normal; full blood count: (14May2021) normal; magnetic resonance imaging head abnormal: (25May2021) normal; metabolic function test: (10May2021) normal; vitamin b12: (14May2021) normal. Therapeutic measures were taken as a result of neuropathy peripheral, hypoaesthesia, paraesthesia.  Clinical course: Patient had not received other vaccine in four weeks. Patient had received Microgestin medications in two weeks. Patient had not Covid prior vaccination. Patient had not Covid tested post vaccination. Patient had not Known allergies.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021581846 same patient, different dose vaccine and different event
Information regarding Flumist was received from a consumer regarding a female pt who experienced a slight rash and a heat-type rash, which she scratched until it bled. Also, the tops of legs and groin area had become irritated and inflamed. The pt received a dose on 12/9/03. On 12/9/03, about two hours post vaccination, the pt developed a "slight rash" on the inside of her elbow joint. Three hrs post vaccination she developed a "heat-type rash" under her breasts. Then, about four hrs post vaccination, the tops of her legs and groin area had become irritated and inflamed. The pt stated that she has scratched until she bled in some parts. As of 12/10/03, the pt had not recovered. No additional info was available at the date of this report.
This spontaneous report as received from a Licensed Practical Nurse via company representative refers to a 70 year old female patient. There were not pertinent medical history or drug allergies reported. On an unspecified date of February 2014, the patient was vaccinated with ZOSTAVAX. The Nurse reported that the patient was diagnosed with Bell's Palsy (medically significant) 14 days after receiving ZOSTAVAX (onset considered approximately on February 2014). The nurse stated that Computerized Tomography (CT) scan was done and ruled out in a stroke in the patient. The reporter reported that there were no other vaccines administered with the ZOSTAVAX. Patient sought medical attention by visiting the office. The patient's present status was reported as recovered (date unspecified). The causality was not reported. No product quality complaint (PQC) was reported. Upon internal review, bell's palsy was determined to be medically significant. Additional information has been requested.
Started with tightness to right jaw, noted while eating dinner approximately 6 hours after vaccination dose #1. Tightness persisted, started taking extra strength tylenol and ibuprofen 400-800 mg as needed. Heat to area also helps. Now two weeks after injection, much improved on tightness but still having pain/TMJ symptoms intermittent.  No numbness/tingling or facial drooping present at any time. Did not restrict daily activities.
Fever (102 - for 30 hours), diarrhea (for 72 hours), stomach cramping/screaming (about 36 hours after vaccine lasting 8 hours), refusal to eat (for 16 hours - about 12 hours after vaccine), rancid dark green poo for 4 weeks, gas and increased reflux symptoms for 4 weeks. ER visit for potential dehydration do to refusal to eat.
Narrative: Covid infection following COVID vaccine series 03/10, Pfizer, dose #1 00/31, Pfizer, dose #2 08 16 pt cc: chills, cough, headache, fatigue, rhinorrhea, congestion exposure: unknown 08/18 COVID swab, result: detected 08/18 SARS-COV-2 Variant Sequencing result: pending
This case was reported by a healthcare professional (also the subject's mother) and described the occurrence of widespread rash in a 3-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline). The subject's medical history included vaccine reaction following MMR vaccine (non-gsk); non-GSK manufacturer; unknown given on an unspecified date. On 4 August 2010 at 15:30 the subject received 1st dose of ENGERIX B (unknown route, left arm). On 10 August 2010, 6 days after vaccination with ENGERIX B, the subject experienced rash on his trunk. The rash spread to his legs and the subject was taken to the doctor on 12 August 2010. At that point, the rash was all over his body. The subject was taken to the Emergency Room on 15 August 2010 and blood work was done (results not specified). The subject was treated with prednisone. At the time of reporting the outcome of the event was unspecified. The vaccination course with ENGERIX B was discontinued.
Shortly after receiving vaccination, pt complained of neck pain and shooting pain going up and down the arm, difficulty pick up arm. Nausea and diarrhea.
Information has been received from a physician through medical records concerning a 1 day old female, who on 12-AUG-2008, was vaccinated with the first dose of RECOMBIVAX HB, manufacturer unknown. On 26-AUG-2008, the 2 week check noted thrush to the infants mouth and a small umbilical hernia. On 30-SEP-2008, the patient was seen for dry skin to the face and ears that had been noted for a week. There was white exudated noted in the infants throat and diaper rash was reported. The child was diagnosed with dry skin, continued thrush and diaper dermatitis, petrolatum, white (VASELINE), nystatin oral solution and nystatin topical cream were prescribed. On 13-OCT-2008, the patient was seen for a 2 month check up. It was reported that thrush was not better, DIFLUCAN was prescribed. The patient was also vaccinated with PEDIARIX, HIB, manufacturer unknown, rotavirus vaccine (unspecified), and pneumococcal conj vaccine (unspecified). On 25-NOV-2008, the patient was seen for diarrhea for one day. The child had 3 diarrhea diapers. The child was noted to be "fine" on the day of the visit. The diagnosis was a questionable milk protein intolerance. Soy formula was prescribed. No skin rash was noted at this visit. Small umbilical hernia was noted to be a congenital anomaly. Additional information has been requested. Medical records provided upon request.
Eight days after initial injection, I noticed an oval-shaped rash about 1.5 x 3 inches over the injection site.  It itches moderately.  No fever, headache or soreness to report.  Rash continues today.
have received the Pfizer vaccine, and have autoimmune disease.; This is a spontaneous report from a contactable consumer (Patient). A 65-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. On an unspecified date, the patient reported that she had received the pfizer vaccine and had experienced autoimmune disease. I am concerned about not knowing how effective the vaccine was in people like me. I would like to participate in a study for booster shots. How many visits were required. Please send me information about qualifying for the study and any other information I might need. Outcome of the event was reported as Unknown.   Follow-up attempts are possible. Information on the lot/batch number has been requested.
Information has been received from a lawyer and a consumer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medications were not provided. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2014, a healthcare provider administered the ZOSTAVAX (lot# and route not provided) vaccine to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related conditions. In 2016, the patient was treated by a health care provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX vaccine, and suffered serious physical, emotional and economic damages as a result of the patient's injuries.  As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
Since vaccination, sperm count has dropped approximately 80 percent; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EW0182), via an unspecified route of administration on arm right on 13May2021 10:30 AM (age at vaccination: 39 years) as dose 2, single for COVID-19 immunization at Pharmacy or Drug Store. The patient medical history and known allergies was reported as none. Device Date was reported as 25Aug2021.The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient Concomitant medications within 2 weeks of vaccination included Zinc Glycinate taken for unspecified indication from an unknown date and Multivitamins. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EW0170), via an unspecified route of administration on arm left on 22Apr2021 11:00 AM (at the age: 39 years) as dose 1, single for COVID-19 immunization. On 17Jun2021, the patient experienced Since vaccination, sperm count has dropped approximately 80%. It was reported that Sperm count before vaccination averaged 78 million, concentration 23 million/mL. Sperm count after vaccination has averaged 16 million, concentration 6 million/mL. This was across 6 semen analyses over 5 months, 2 before vaccination, 4 after vaccination. The adverse event resulted in Doctor or other healthcare professional office/clinic visit/ Disability or permanent damage. The lab test included Sperm concentration: averaged 78 million, concentration 23 million/ml (Before vaccination 2 semen analysis) and Sperm concentration: averaged 16 million, concentration 6 million/ml (After vaccination 4 semen analysis) on an unknown date in 2021. The treatment received for the events was reported as no. The outcome of event was unknown.  Follow-Up (27Aug2021): Follow-up attempts are completed. No further information is expected.
This case was reported by an office administrator at a physician's office and described her 20 year old son who did not respond to immunization with hep B vaccine (manf unk). On unspecified dates, the pt received three doses of hep b vaccine (manf unk). On an unspecified date, a hep B surface antibody titer was negative. On 07Dec03, the pt inadvertently received the pediatric dose of hep B vaccine recombinant (Engerix B) as the first dose of a second series of hep B vaccination.